Liquidity
Watch1.05
How the figure is assessed
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
Org. no. 968 655 973 · Private limited company (AS) · Active · Gaustadalléen 21, 0349, OSLO · OSLO · 86.910 – Medical laboratory and diagnostic imaging activities
VITAS AS is a private limited company (as) registered in OSLO since 1994. The organisation number is 968 655 973. The register lists 36 employees. The latest submitted annual accounts are for 2025.
Source: The Brønnøysund Register Centre · Last updated 21 November 2026 at 00:23
Quick overview
Based on the latest submitted annual accounts (2025) and registry data.
1.05
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
40.2 %
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
8.2 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Calculated by us
Based on status, solvency, liquidity, profitability, trend and how recent the accounts are. Public register data only.
This is an indicative assessment, not a credit rating. It does not replace your own due diligence before entering into an agreement.
Proffi+
Calculating …
Indicative model estimate based on public accounting figures and typical industry multiples. Not an appraisal, a valuation or investment advice.
Development
Revenue and profit
RevenueResult
Development
Solvency and profitability (%)
SolidityProfitability
Registry data
Addresses
Industry
Medical laboratory and diagnostic imaging activities(main industry)
Q Human health and social work activities › 86 Human health activities › 86.9 Other human health activities › 86.91 Medical laboratory and diagnostic imaging activities
See the industry: largest companies and key figures →Omfatter: Analyser og diagnostikk ved medisinske laboratorier (med unntak av selve den medisinske analysen og tolkningen), herunder analyse av kroppsvæsker eller genetisk testing som tilbys direkte til polikliniske pasienter med eller uten henvisning fra helsepersonell, slik som; Aktiviteter ved røntgenlaboratorier og andre diagnostiske bildebehandlingssentre. Aktiviteter ved laboratorier for blodanalyse. DNA-sekvensering for å utelukke eller kurere en spesifikk sykdom. Omfatter også: Laboratorietjenester knyttet til dopingkontroll. Ekskluderer: Ikke-medisinsk laboratorietesting som tester innenfor matvarehygiene og tjenester ved rettsmedisinske laboratorier grupperes under 71.20 Teknisk prøving og analyse. Medisinsk analyse og tolkning av diagnostiske medisinske bilder (røntgen, elektrokardiogram, endoskopier og lignende) grupperes under 86.22 Spesialiserte legetjeneste. Aktiviteter ved gendatabaser, blod- og organbanker grupperes under 86.99 Andre helsetjenester ikke nevnt annet sted. Sykehusenes røntgen- og laboratorieavdelinger grupperes under 86.10 Sykehustjenester.
Institutional sector code: Private aksjeselskaper mv. (2100)
Selskapet er et kommersielt oppdragslaboratorie som har til formål å drive forskning og utvikling, samt leveranse av rasjonelle laboratorie- og kontrolltjenester spesielt innen områdene klinisk kjemi, legemiddel utvikling, bioteknologi, næringsmiddelproduksjon og oljeutvinning
Registry status
Experiences
Loading reviews …
You must sign in with a verified email to write a review.
Financial overview
Fiscal year 2025 · Amounts in NOK
Data basis
3 stored years
1.05
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
40.2 %
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
8.2 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Only reported amounts from the Register of Company Accounts
| Accounting item | 2025 | 2024 | 2023 | Development |
|---|---|---|---|---|
| Operating revenue | 89,792,519 | 77,625,607 | 64,025,129 | |
| Operating profit | 36,066,120 | 28,791,733 | 19,287,544 | |
| Profit before tax | 36,665,361 | 29,284,915 | 19,207,913 | |
| Net result | 28,604,039 | 23,157,385 | 15,292,277 | |
| Total assets | 44,190,199 | 41,364,241 | 34,985,734 | |
| Equity | 3,619,784 | 3,281,104 | 5,393,136 | |
| Liabilities | 40,570,414 | 38,083,137 | 29,592,598 |
Graphical analysis
Amounts in NOK
Calculated by us, in percent
Balance sheet in NOK
Register of Company Accounts
Period 2025-01-01 to 2025-12-31. Currency NOK. Audited annual accounts.
| Total operating revenue | 89,792,519 NOK |
|---|---|
| Total operating expenses | 53,726,398 NOK |
| Operating profit | 36,066,120 NOK |
| Total financial income | 738,787 NOK |
| Total financial expenses | 139,546 NOK |
| Net financial items | 599,240 NOK |
| Profit before tax | 36,665,361 NOK |
| Net result | 28,604,039 NOK |
| Total fixed assets | 1,693,951 NOK |
|---|---|
| Total current assets | 42,496,248 NOK |
| Total assets | 44,190,199 NOK |
| Paid-in equity | 3,226,632 NOK |
|---|---|
| Retained earnings | 393,153 NOK |
| Total equity | 3,619,784 NOK |
| Current liabilities | 40,570,414 NOK |
| Total debt | 40,570,414 NOK |
| Total equity and liabilities | 44,190,199 NOK |
Register of Company Accounts
Period 2024-01-01 to 2024-12-31. Currency NOK. Audited annual accounts.
| Total operating revenue | 77,625,607 NOK |
|---|---|
| Total operating expenses | 48,833,873 NOK |
| Operating profit | 28,791,733 NOK |
| Total financial income | 623,042 NOK |
| Total financial expenses | 129,860 NOK |
| Net financial items | 493,182 NOK |
| Profit before tax | 29,284,915 NOK |
| Net result | 23,157,385 NOK |
| Total fixed assets | 1,669,780 NOK |
|---|---|
| Total current assets | 39,694,461 NOK |
| Total assets | 41,364,241 NOK |
| Paid-in equity | 3,226,632 NOK |
|---|---|
| Retained earnings | 54,472 NOK |
| Total equity | 3,281,104 NOK |
| Current liabilities | 38,083,137 NOK |
| Long-term liabilities | 0 NOK |
| Total debt | 38,083,137 NOK |
| Total equity and liabilities | 41,364,241 NOK |
Register of Company Accounts
Period 2023-01-01 to 2023-12-31. Currency NOK. Audited annual accounts.
| Total operating revenue | 64,025,129 NOK |
|---|---|
| Total operating expenses | 44,737,585 NOK |
| Operating profit | 19,287,544 NOK |
| Total financial income | 77,806 NOK |
| Total financial expenses | 157,437 NOK |
| Net financial items | -79,631 NOK |
| Profit before tax | 19,207,913 NOK |
| Net result | 15,292,277 NOK |
| Total fixed assets | 1,862,726 NOK |
|---|---|
| Total current assets | 33,123,008 NOK |
| Total assets | 34,985,734 NOK |
| Paid-in equity | 1,515,481 NOK |
|---|---|
| Retained earnings | 3,877,655 NOK |
| Total equity | 5,393,136 NOK |
| Current liabilities | 29,592,598 NOK |
| Long-term liabilities | 0 NOK |
| Total debt | 29,592,598 NOK |
| Total equity and liabilities | 34,985,734 NOK |
Source: Register of Company Accounts, Brønnøysund Register Centre. Figures are shown as submitted, and historical years are never overwritten by newer submissions.
Calculated by us
| Key figures | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue growthChange in total operating revenue from the previous fiscal year. | 15.7 % | 21.2 % | – |
| Operating marginOperating profit divided by total operating revenue. | 40.2 % | 37.1 % | 30.1 % |
| Profit marginOrdinary profit before tax divided by total operating revenue. | 40.8 % | 37.7 % | 30 % |
| Equity ratioTotal equity divided by total assets. | 8.2 % | 7.9 % | 15.4 % |
| Current ratioTotal current assets divided by total current liabilities. | 1.05 | 1.04 | 1.12 |
| Debt ratioTotal liabilities divided by total equity. | 11.21 | 11.61 | 5.49 |
| Return on assetsOrdinary profit before tax plus financial expenses, divided by total assets. | 83.3 % | 71.1 % | 55.4 % |
| Return on equityNet profit divided by total equity. | 790.2 % | 705.8 % | 283.6 % |
About the calculation
The key figures are calculated by us (formula version v1) from public accounts in the Register of Company Accounts. A figure is only calculated when all input values exist and the denominator is not zero. The figures are not a credit assessment.
Registry data
Source: The Brønnøysund Register Centre. We only show name and role as published by the register – never date of birth or private address.
Structure
Overview
VITAS AS
OSLO · 36 employees
Registry data
| Name | Org. no. | Place | Employees |
|---|---|---|---|
| VITAS ASMedical laboratory and diagnostic imaging activities | 973 899 775 | OSLO | 36 |
This has not been registered yet. We never show made-up information.
Services and products
The company has not added any services yet.
Public approvals
Not in the Norwegian Building Authority's central approval register.
Public contracts
No notices found in TED where the company is a supplier or contracting authority.
Registered changes
We show changes from the Brønnøysund Register Centre's change log from the next registered change.
Documents
Certificates of registration and other documents require a separate agreement with a document provider.
Transparency
Company information
Brønnøysund Register Centre · Public register
Last retrieved 21 November 2026 at 00:23
Open official sourceRoles
Brønnøysund Register Centre · Public register
Last retrieved 21 November 2026 at 00:23
Open official sourceAccounts and key figures
Register of Company Accounts · Public register
Last retrieved 21 November 2026 at 00:23
Open official sourceAddress (verified)
Norwegian Mapping Authority – Geonorge address API · Public register
Last retrieved 21 November 2026 at 00:23
Open official sourceCentral approval
Norwegian Building Authority (DiBK) · No approval found
Last retrieved 21 November 2026 at 00:23
Open official sourceIndustry standard (SN2007)
Statistics Norway – KLASS · Official standard
Last retrieved 21 November 2026 at 00:23
Open official sourcePublic registry data is updated periodically and cannot be changed by the company. Calculated figures are marked “Calculated by us”.
Report an errorSource
Public registry fields on this page come from the Central Coordinating Register and cannot be changed by the company. Self-reported content is marked separately.
Read about the data sourcesTalk to Proffi
Leave your contact details and an adviser will explain how segmentation, company profiles and supplier search can support your business.